A new call for Innovation Partnership Grants between Swiss academia and Japanese innovation agents including industry and start-ups is now open. All scientific disciplines including social sciences and humanities are eligible. Selected projects will receive funding up to 20k CHF for a duration of up to 12 months.
Switzerland related news
Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced that it is working to start a Phase III clinical trial in Japan with the humanized anti-human IL-6 receptor monoclonal antibody, “Actemra® Intravenous Infusion 80 mg, 200 mg, and 400 mg” [generic name: tocilizumab (genetical recombination)] in COVID-19 pneumonia.
Numab Therapeutics and the Japanese based Ono Pharmaceutical have extended their relationship by executing another research and option agreement to discover and develop a multi-specific antibody drug candidate for the treatment of various cancers. Ono will again pay to Numab up to CHF 260 million in upfront and milestone payments.
Mitsubishi Chemical Corporation recently decided that it will acquire two Swiss engineering plastics recyclers, Minger Kunststofftechnik AG and Minger Plastic AG (collectively, the Minger Group), through its group company Mitsubishi Chemical Advanced Materials as a part of the company’s efforts to promote the circular economy. The acquisition is expected to be completed by the end of February this year.
In the first “Saira Rumantscha - Romansh-Speaking Evening”, the Embassy of Switzerland welcomed the authors of a book on Romansh language and culture written in Japanese.
HESAV and Teikyo University celebrated a successful conclusion to this year’s round of university student exchange in the field of radiology at the Embassy of Switzerland in Japan.
A health ministry panel approved Wednesday the production and sale of a gene therapy for treating spinal muscular atrophy, a rare incurable disease that destroys muscle function through a decrease in motor neuron cells.
With COVID-19 spreading from China to other countries, pharmaceutical, chemical and other companies are rushing to develop quick test kits that promise to facilitate quarantine procedures.
The heads of six central banks and the Bank for International Settlements in mid-April will hold their first meeting on developing their own digital currencies, which can serve as alternatives to Facebook's Libra or the digital yuan.
Federal Cyber Security Delegate, Mr. Florian Schütz, visits Tokyo and delivers a keynote speech at the SIP Symposium on “Cybersecurity for Critical Infrastructure”.